Background: Cancer is the second leading cause of death in women of reproductive age. The most common tumors diagnosed during pregnancy are breast and cervix cancer, Hodgkin lymphoma and non-Hodgkin lymphoma, leukemias, and malignant melanoma. The aim of therapy in pregnancy is to give optimal treatment to the mother without harm to the fetus. In the first trimester, organogenesis continues, so chemotherapy should not be given because of increasing risk of spontaneous abortion, fetal malformation, and mortality. We evaluated mostly seen tumors during pregnancy and assessed treatment type and outcome of pregnancy after chemotherapy in our population
AbstractMalignancy is the second most common cause of mortality in the reproductive period and it co...
Cancer is the second leading cause of death in women during their reproductive years, and complicate...
Cancer is the second most common cause of death in women during their reproductive years, and compli...
Background: Cancer is the second leading cause of death in women of reproductive age. The most commo...
Cancer complicates approximately 1 in 1000 pregnancies. In pregnancy management, whether the benefit...
Cancer diagnosed during pregnancy is uncommon, complicating between 0.02% and 0.1% of all pregnancie...
A multidisciplinary discussion is necessary to tackle a complex and infrequent medical problem such ...
Cancer during pregnancy is occurring more often than in the past, and it is estimated that cancer is...
Contains fulltext : 70118.pdf (publisher's version ) (Closed access)In this review...
One in 1000 pregnancies is complicated by maternal cancer. The most frequently encountered malignanc...
In this review current knowledge on prevalence, diagnosis, treatment and prognosis of gynaecological...
Cancer in pregnancy though rare is a challenging problem both for patient and obstetrician. It is on...
A malignancy discovered in pregnancy is often difficult to manage; the optimal maternal therapy has ...
Purpose The aim of this study was to assess the management and the obstetrical and neonatal outcomes...
Elyce Cardonick Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Cooper...
AbstractMalignancy is the second most common cause of mortality in the reproductive period and it co...
Cancer is the second leading cause of death in women during their reproductive years, and complicate...
Cancer is the second most common cause of death in women during their reproductive years, and compli...
Background: Cancer is the second leading cause of death in women of reproductive age. The most commo...
Cancer complicates approximately 1 in 1000 pregnancies. In pregnancy management, whether the benefit...
Cancer diagnosed during pregnancy is uncommon, complicating between 0.02% and 0.1% of all pregnancie...
A multidisciplinary discussion is necessary to tackle a complex and infrequent medical problem such ...
Cancer during pregnancy is occurring more often than in the past, and it is estimated that cancer is...
Contains fulltext : 70118.pdf (publisher's version ) (Closed access)In this review...
One in 1000 pregnancies is complicated by maternal cancer. The most frequently encountered malignanc...
In this review current knowledge on prevalence, diagnosis, treatment and prognosis of gynaecological...
Cancer in pregnancy though rare is a challenging problem both for patient and obstetrician. It is on...
A malignancy discovered in pregnancy is often difficult to manage; the optimal maternal therapy has ...
Purpose The aim of this study was to assess the management and the obstetrical and neonatal outcomes...
Elyce Cardonick Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Cooper...
AbstractMalignancy is the second most common cause of mortality in the reproductive period and it co...
Cancer is the second leading cause of death in women during their reproductive years, and complicate...
Cancer is the second most common cause of death in women during their reproductive years, and compli...